Menthofuran

Last updated
Menthofuran
Menthofuran.svg
Names
IUPAC name
3,6-Dimethyl-4,5,6,7-tetrahydro-1-benzofuran
Identifiers
3D model (JSmol)
ChEBI
ChemSpider
ECHA InfoCard 100.007.087 OOjs UI icon edit-ltr-progressive.svg
PubChem CID
UNII
  • InChI=1S/C10H14O/c1-7-3-4-9-8(2)6-11-10(9)5-7/h6-7H,3-5H2,1-2H3
    Key: YGWKXXYGDYYFJU-UHFFFAOYSA-N
  • InChI=1/C10H14O/c1-7-3-4-9-8(2)6-11-10(9)5-7/h6-7H,3-5H2,1-2H3
    Key: YGWKXXYGDYYFJU-UHFFFAOYAW
  • o1c2c(c(c1)C)CCC(C2)C
Properties
C10H14O
Molar mass 150.221 g·mol−1
Boiling point 208
Hazards
Flash point 86
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).

Menthofuran is an organic compound found in a variety of essential oils including that of pennyroyal (Mentha pulegium). It is highly toxic and believed to be the primary toxin in pennyroyal responsible for its potentially fatal effects. [1] After ingestion of menthofuran, it is metabolically activated to chemically reactive intermediates that are hepatotoxic. [2]

Contents

Biosynthesis

Menthofuran is produced biosynthetically from pulegone by the enzyme menthofuran synthase.

Menthofuran synthase converts pulegone to menthofuran (+)-menthofuran synthase reaction.PNG
Menthofuran synthase converts pulegone to menthofuran

Chemistry

Synthesis

Menthofuran can be synthesized from 5-methylcyclohexane-1,3-dione and allenyldimethylsulfonium bromide in two steps via a furannulation strategy consisting of enolate addition and rearrangement. [3]

Pharmacology

Menthofuran is a metabolite of pulegone. Both in vitro and in vivo studies have found the pulegone metabolite menthofuran to be an inhibitor of CYP2A6. [4] [5] [6] [7]

Menthofuran may deplete glutathione levels, leaving hepatocytes vulnerable to free radical damage. [5]

References

  1. ↑ Anderson IB, Mullen WH, Meeker JE, Khojasteh-BakhtSC, Oishi S, Nelson SD, Blanc PD (April 1996). "Pennyroyal toxicity: measurement of toxic metabolite levels in two cases and review of the literature". Annals of Internal Medicine. 124 (8): 726–34. doi:10.7326/0003-4819-124-8-199604150-00004. PMID   8633832. S2CID   24375611.
  2. ↑ Thomassen D, Knebel N, Slattery JT, McClanahan RH, Nelson SD (1992). "Reactive intermediates in the oxidation of menthofuran by cytochromes P-450". Chemical Research in Toxicology. 5 (1): 123–30. doi:10.1021/tx00025a021. PMID   1581528.
  3. ↑ Mariko Aso; Sakamoto, Mizue; Urakawa, Narumi; Kanematsu, Ken (1990). "Furannulation strategy. An efficient synthesis of fused 3-methylfurans". Heterocycles. 31 (6): 1003–6. doi: 10.3987/com-90-5392 .
  4. ↑ Khojasteh-Bakh, S. C.; Koenigs, L. L.; Peter, R. M.; Trager, W. F.; Nelson, S. D. (July 1998). "(R)-(+)-Menthofuran is a potent, mechanism-based inactivator of human liver cytochrome P450 2A6". Drug Metabolism and Disposition. 26 (7): 701–704. PMID   9660853.
  5. 1 2 Gordon, W. P.; Huitric, A. C.; Seth, C. L.; McClanahan, R. H.; Nelson, S. D. (February 26, 1989). "The metabolism of the abortifacient terpene, (R)-(+)-pulegone, to a proximate toxin, menthofuran". Drug Metabolism and Disposition. 15 (5): 589–594. doi:10.1016/S0090-9556(25)06790-X. PMID   2891472.
  6. ↑ Thomassen, D.; Pearson, P. G.; Slattery, J. T.; Nelson, S. D. (January 17, 1991). "Partial characterization of biliary metabolites of pulegone by tandem mass spectrometry. Detection of glucuronide, glutathione, and glutathionyl glucuronide conjugates". Drug Metabolism and Disposition. 19 (5): 997–104. doi:10.1016/S0090-9556(25)08983-4. PMID   1686249.
  7. ↑ Kramlinger VM, von Weymarn LB, Murphy SE (May 2012). "Inhibition and inactivation of cytochrome P450 2A6 and cytochrome P450 2A13 by menthofuran, β-nicotyrine and menthol". Chemico-Biological Interactions . 197 (2–3): 87–92. Bibcode:2012CBI...197...87K. doi:10.1016/j.cbi.2012.03.009. PMC   3362486 . PMID   22486895.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.